Medication Review Improves Pain Management and Quality of Life in Chronic Pain

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 3, 2023

Primary Completion Date

June 26, 2024

Study Completion Date

June 26, 2024

Conditions
Chronic Pain
Interventions
OTHER

Medication Review Type III

The MR arm will receive four MR interviews. In the first MR, information about the patient's personal and medical history, along with current health problems, relevant lab exams and medication will be gathered. This will be used to proceed with medication review process and assessment of Drug Related Problems (DRP) that may lead to negative medication results. A personalized care plan will be developed to correct any detected DRP, delivered in writing/e-mail to the patient and carefully explained. Some DRP's may need the physician's intervention to correct. In these cases, a detailed recommendation will be sent to the patient's physician via email. All physicians' recommendations acted upon or not, will be recorded. Subsequent interviews will assess patient compliance with the care plan and if necessary, adjustments will be made accordingly.

OTHER

Usual Care

The UC arm will receive an intervention by the investigator at the same time frame defined for the MR arm. The intervention will also consist of interviews, although MR will not be conducted. The investigator will ask questions to the patient about is drug therapy in a similar fashion to what would happen in the community pharmacy. Simple advice and information will be carried out (i.e., reinforcement of adherence, explanation about indication of drugs etc.)

Trial Locations (1)

4200-072

Centro de Investigação em Saúde e Ambiente (CISA) - School of Health of the Polytechnic Institute of Porto, Porto

All Listed Sponsors
collaborator

University of Salamanca

OTHER

lead

Polytechnic Institute of Porto

OTHER

NCT06997861 - Medication Review Improves Pain Management and Quality of Life in Chronic Pain | Biotech Hunter | Biotech Hunter